Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Leukemia & Lymphoma|April 24, 2025
Risk factors for influenza virus infection in patients with hematological diseaseHirotomo Nakashima, Shin-Ichiro Fujiwara, Seina Honda, et al.
Leukemia Research|November 19, 2021
Relationship of tumor load parameters before and after autologous stem cell transplantation with clinical prognosis in transplant-eligible patients with multiple myeloma: A retrospective analysisDaisuke Minakata, Shin-Ichiro Fujiwara, Rui Murahashi, et al.
Transplantation and Cellular Therapy|February 15, 2025
Impact of Real-World Clinical Factors on an Analysis of the Cost-Effectiveness of "Immediate CAR-T" Versus "Late CAR-T" as Second-Line Treatment for DLBCL PatientsChihiro Yamamoto, Seina Honda, Ryutaro Tominaga, et al.
Cancer Genetics|January 10, 2018
A leukemic double-hit follicular lymphoma associated with a complex variant translocation, t(8;14;18)(q24;q32;q21), involving BCL2, MYC, and IGHDaisuke Minakata, Kazuya Sato, Takashi Ikeda, et al.
Annals of Hematology|June 24, 2020
Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myelomaTakashi Nagayama, Masahiro Ashizawa, Takashi Ikeda, et al.
Annals of Hematology|June 27, 2019
Predictive value of soluble interlukin-2 receptor level at diagnosis on the outcome for patients with classical Hodgkin lymphoma treated with ABVD with or without radiotherapyKento Umino, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 17, 2020
Steep neutrophil recovery following unrelated bone marrow transplantation is a major risk factor for the development of acute graft-vs-host disease-a retrospective studyTakashi Nagayama, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Leukemia & Lymphoma|April 6, 2019
Impact of the soluble interleukin-2 receptor level in the relapsed or refractory phase on the clinical outcome of patients with diffuse large B-cell lymphomaKento Umino, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Pathology, Research and Practice|September 26, 2024
T-ALL presenting with i-TLP-like indolent clinical course with repeated spontaneous regressionsYumiko Toda, Ken Ohmine, Naoki Sano, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2019
Salvage Chemotherapy Followed by Autologous Stem-Cell Transplantation Using Targeted Busulfan for Refractory Diffuse Large B-Cell Lymphoma With Dialysis-Dependent End-Stage Renal DiseaseKaoru Morita, Masahiro Ashizawa, Yumiko Toda, et al.
Pageof 6